WILMINGTON – Seeking to grow its international market for a skin cream that can treat a variety of conditions from eczema to vitiligo, Incyte has signed a collaboration and license […]
WILMINGTON – Incyte secured on Monday the first U.S. Food & Drug Administration approval for a treatment of the skin pigmentation disorder vitiligo, demonstrating the growing strength of the biopharmaceutical […]
WILMINGTON – After many years of growing widely across the greater Wilmington area, the drugmaker Incyte Corp. is bringing 300 of its employees to its headquarters campus in Alapocas with […]
WILMINGTON – Incyte Corp. announced Monday that it has signed a collaboration and license agreement valued at up to $117.5 million with InnoCare, a Chinese biopharmaceutical company. The deal gives […]
© 2023 Delaware Business Times